Yu-Jung Chen Selected Research

GalNAc- 1- 3- (Fuc- 1- 2)Gal- 1- 3- GlcNAc- 1- 3- Gal- 1- 4- Glc- PA

1/2021

Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Jung Chen Research Topics

Disease

3	Neoplasms (Cancer) 01/2021 - 01/2019
2	Tremor (Tremors) 03/2018 - 01/2016
2	Infections 01/2018 - 07/2017
2	Inflammation (Inflammations) 12/2014 - 05/2010
2	Peritonitis 12/2014 - 05/2010
2	Sepsis (Septicemia) 12/2014 - 05/2010
1	Neurofibrosarcoma (MPNST) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Pneumonia (Pneumonitis) 01/2018
1	Non-alcoholic Fatty Liver Disease 07/2017
1	Hepatitis A (Hepatitis, Infectious) 07/2017
1	Chronic Hepatitis B 07/2017
1	Rhabdomyolysis 08/2016
1	Communicable Diseases (Infectious Diseases) 08/2016
1	Acute Kidney Injury (Acute Renal Failure) 08/2016
1	Mental Disorders (Mental Disorder) 08/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2016
1	Vitiligo 06/2016
1	Essential Tremor (Essential Tremors) 01/2016
1	Septic Shock (Toxic Shock Syndrome) 12/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2013
1	Schizophrenia (Dementia Praecox) 10/2012
1	Breast Neoplasms (Breast Cancer) 06/2011
1	Carcinogenesis 06/2011
1	Delirium 05/2010
1	Cardiomyopathies (Cardiomyopathy) 05/2010
1	Brain Neoplasms (Brain Tumor) 03/2010
1	Thymoma (Thymic Carcinoma) 03/2010
1	Seizures (Absence Seizure) 02/2010
1	Insulin Resistance 01/2010
1	Hyperglycemia 05/2008

Drug/Important Bio-Agent (IBA)

2	Insulin (Novolin)FDA Link 01/2010 - 05/2008
1	NestinIBA 01/2021
1	Antimitotic AgentsIBA 01/2021
1	GalNAc- 1- 3- (Fuc- 1- 2)Gal- 1- 3- GlcNAc- 1- 3- Gal- 1- 4- Glc- PAIBA 01/2021
1	Globo-HIBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2019
1	TabletsIBA 03/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Galectin 3 (LGALS3)IBA 01/2018
1	InflammasomesIBA 01/2018
1	Alanine Transaminase (SGPT)IBA 07/2017
1	Hemoglobins (Hemoglobin)IBA 07/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2017
1	Toll-Like Receptor 4IBA 12/2014
1	EndotoxinsIBA 12/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2014
1	salicylhydroxamic acid (SHAM)IBA 12/2014
1	Uric Acid (Urate)IBA 12/2013
1	Messenger RNA (mRNA)IBA 10/2012
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2011
1	Diphenhydramine (Benadryl)FDA LinkGeneric 05/2010
1	Nefopam (Ajan)IBA 05/2010
1	Toll-Like Receptor 2IBA 05/2010
1	Aripiprazole (Abilify)FDA Link 02/2010
1	Glucose (Dextrose)FDA LinkGeneric 01/2010
1	CytokinesIBA 01/2010
1	Antidepressive Agents (Antidepressants)IBA 01/2010
1	Blood Glucose (Blood Sugar)IBA 05/2008
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 05/2008

Therapy/Procedure

2	Punctures 12/2014 - 05/2010
2	Ligation 12/2014 - 05/2010
1	Immunotherapy 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Therapeutics 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Orthopedic Procedures 08/2016
1	Phototherapy (Light Therapy) 06/2016
1	Optical Devices 01/2016
1	Radiotherapy 03/2010